The majority of serovars deemed to be invasive in the United States are also invasive globally; however, some that are presently invasive in the United States are not causing invasive disease elsewhere in the world, indicating geographic distribution plays a role in the percentage of invasive disease caused by a particular serovar. This finding is supported by other recent reports; for example, the invasive index of serovar Schwarzengrund is 15.4% in both the United States and Brazil [3] but is 25% in Taiwan [4] . Another, more worrying example comes from several subSaharan African countries, where NTS are now the most common cause of bacteremia. In these countries, cases of invasive disease have been attributed to serovars Typhimurium and Enteritidis, occurring in epidemics of disease caused by antibiotic-resistant strains associated with HIV status and age [5] .
We believe that it is likely that the severity of salmonellosis caused by different serovars is related not only to humanhost factors [6] but also to bacterial phylogeny [7] . Twenty years ago, studies using multilocus enzyme electrophoresis showed that some serovars are single genetic entities (monomorphic), whereas others are clearly mixtures of strains [8] . These data are now supported by multilocus sequence typing (MLST), and certain groupings known by a single serovar name actually represent genetically distinct groups that may cause different disease outcomes in humans. For this reason, we propose that, where possible, descriptions of disease severity should be associated with sequence types obtained by MLST, as well as with serovars. An extensive open-access database (http:// web.mpiib-berlin.mpg.de/mlst/) of sequence types of Salmonella enterica is available that will help to achieve this goal. 
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